Advertisement

Approved Drugs

  • Siamak Cyrus KhojastehEmail author
  • Harvey Wong
  • Cornelis E. C. A. Hop
Chapter

Abstract

Here we represent resources available, including FDA web sites, for information on the drug approval process and Critical Path Initiatives. We include information on the cost of clinical drug development, approved drugs since 1995, the largest pharmaceutical companies based on pharmaceutical sales, the top selling drugs in 2009, and the approved drugs in the first half of 2010.

Abbreviations

CDER

Center for Drug Evaluation and Research

CPI

Critical Path Initiative

IND

Investigational new drug

NDA

New drug application

References

  1. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151–185PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Siamak Cyrus Khojasteh
    • 1
    Email author
  • Harvey Wong
    • 1
  • Cornelis E. C. A. Hop
    • 1
  1. 1.Genentech, Inc.San FranciscoUSA

Personalised recommendations